Studies on mice lacking the peroxisome proliferator-activated receptor (PPA
R) suggest that PPAR ligands reduce lipid accumulation in foamy macrophages
, and may target other receptors. These findings warrant an in-depth invest
igation into the gene regulatory mechanisms of PPAR ligands, which are curr
ently being developed as drugs to treat atherosclerosis and diabetes.